explored the mechanism of β‐ST in DLBCL and found that it modulates sphingolipid metabolism, promotes acid sphingomyelinase (ASM) to the plasma membrane, and regulates the ASM/ceramide signaling pathway, thereby enhancing the therapeutic effect of RTX on DLBCL. Here, SMPD1 is linked to diffuse large B-cell lymphoma.